News and events
LHF Espoir and Artistes Sportifs de Cœur present a cheque to the biotherapy team
The LHF Espoir and Artistes Sportifs de Cœur associations presented a cheque to the biotherapy team to support its research project to administer mRNA
Intracellular Delivery of Functional Proteins with DNA–Protein Nanogels–Lipids Complex
The Biotherapy team, in collaboration with the Nanobiosciences and microsystems team of unit 8640 of the CNRS (P.A.S.T.E.U.R) of the Ecole Normale Supérieure, has just published an article in the Journal of the American Chemical Society on the intracellular...
Special angle on rare diseases : Daniel Scherman
“Le Monde” will publish an article on rare diseases, in collaboration with Daniel Schermann.
Alliance Recherche Innovation Industries Santé: Nathalie Mignet and Barthelemy Philippe presented promising new approaches to the use of nucleic acids.
Alliance Recherche Innovation Industries Santé: Nathalie Mignet and Barthelemy Philippe presented promising new approaches to the use of nucleic acids.
The ProteRNA project, Success Story of the month in the SATT network
This project aims to offer RNA vaccines that can be administered orally. It is based on a method of manufacturing tablets containing nucleic acid vectors, which can be stored at room temperature.
A collaboration between UTCBS and I2M (Bordeaux)
SFnano 2023 Pauline wins best poster award!
SFnano 2023
Ouverture d’un poste AI Mobilité Interne CNRS (FSEP)
Nous avons obtenu un poste en mobilité CNRS (FSEP) pour notre plateforme d’imagerie LIOPA ( affilié PIV imagerie du vivant université paris Cité ) Profil : Assistant Ingénieur expérimentation animal. Contacts : Nathalie Mignet Johanne Seguin Fiche de poste : Fiche de...
Shanghai ranks Université Paris Cité 3rd
Shanghai ranks Université Paris Cité 3rd
Team Vecteur and Materia Nova make the front page of ChemSusChem
Team Vecteur and Materia Nova make the front page of ChemSusChem
The Nobel Prize
Nobel Prize of Physiology or Medicine 2023 toKatalin Karikó and Drew Weissman for their discoveries on nucleoside base modifications that enabled the development of effective mRNA vaccines against Covid-19.
Validation of a formulation from UTCBS to reduce recurrence rates after local treatment of colorectal cancer,
A new formulation for the treatment and prevention of colon cancer metastases.
Start-up Imisca and Erganeo have signed an exclusive license for a new gel-forming solution to reduce recurrence rates after local treatment of colorectal cancer, improve patient survival and optimize treatment.
UTCBS takes part in the 6th NanoMed Workshop in Patras (Greece)
From July 10 to 12, 2023, the 6th EMJMD NanoMed Workshop will be held in Patras (Greece) on the theme of positioning Nanomedicine in the post-vaccine RNA-messenger era.